Component information
No US or EU label exists for this exact combination, so information is shown for each component.
Use: TRADJENTA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus . US FDA label
Kidney dosing: Linagliptin (single-agent)Show full dosing details
- eGFR ≥60
- 5 mg once daily; no adjustment (label).
- eGFR 30–59
- 5 mg once daily; no adjustment (label).
- eGFR 15–29
- 5 mg once daily; no adjustment (label). Studied in CARMELINA (15% had eGFR <30).
- eGFR <15 (not on dialysis)
- No adjustment recommended for renal impairment (label).
- Hemodialysis (intermittent)
- No adjustment in label (renal-impairment PK study did not include dialysis); removal by hemodialysis unlikely. Hypoglycemia risk higher with insulin in severe kidney impairment (label 5.2).
- Peritoneal dialysis
- No adjustment in label (renal-impairment PK study did not include dialysis); removal by peritoneal dialysis unlikely. Hypoglycemia risk higher with insulin in severe kidney impairment (label 5.2).
- CRRT
- No data in label.
- Dialyzable? Unlikely (label).
- Monitoring Hypoglycemia with sulfonylureas or insulin; pancreatitis; bullous pemphigoid.
From the Linagliptin monograph (renalcarematters.com, reviewed).
- metformin hyydrochloride no separate page
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Film-coated tablet: 2.5 mg/1 g, 2.5 mg/500 mg, 2.5 mg/850 mg
Registered products in the Philippines
3 products registered with the Food and Drug Administration (FDA) Philippines list Linagliptin + Metformin hyydrochloride as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products3
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
Trajenta DuoLinagliptin + Metformin Hyydrochloride | 2.5mg/1g Film-Coated TabletHDPE bottle with PP screw cap containing 60 tablets (Box of 60 tablets) | Rx | Boehringer Ingelheim Promeco, S.A. de C.V.Mexico | Importer: Boehringer Ingelheim (Philippines), Inc. | DR-XY 47929 | Apr 12, 2027 | |
Trajenta DuoLinagliptin + Metformin Hyydrochloride | 2.5mg/500mg Film-Coated TabletHDPE bottle with PP screw cap containing 60 tablets (Box of 60 tablets) | Rx | Boehringer Ingelheim Promeco, S.A. de C.V.Mexico | Importer: Boehringer Ingelheim (Philippines), Inc. | DR-XY 48038 | May 25, 2027 | |
Trajenta DuoLinagliptin + Metformin Hyydrochloride | 2.5mg/850mg Film-Coated TabletHDPE bottle with PP screw cap containing 60 tablets (Box of 60 tablets) | Rx | Boehringer Ingelheim Promeco, S.A. de C.V.Mexico | Importer: Boehringer Ingelheim (Philippines), Inc. | DR-XY47930 | Apr 12, 2027 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .